nanobiotix

Cancer is one of the leading causes of death worldwide and accounted for 7.6 million deaths (around 13% of all deaths) in 2008. In the Western World and in the U.S. cancer represents the second-leading cause of death after heart attack.

Emerging countries are facing more and more the increase of cancer incidence which represents 60% of the death in these countries.

Nanobiotix is a nanomedicine company focused on the development of innovative nanoparticle technology: NanoXray pipeline which has the potential to cause a paradigm shift in cancer therapy. Specifically, NanoXray products may bring solution to current limitations of standard of care in local therapy. Local treatment plays a seminal role in the potential cure or gives a better chance to systemic treatment to increase life expectancy.